Key Visual Siemens Healthineers Quantum Technology showing the face of a middle-aged women, next to the abstract visualization of a photon-counting detector with its precise pulses and the clinical image of an abdomen in the center of the pulses.

Redefine oncology CT
with NAEOTOM Alpha®  
Turn each scan into accurate decisions

In oncology, accurate and precise imaging plays a pivotal role in diagnosis, treatment planning, and monitoring the effectiveness of therapies. NAEOTOM Alpha with its groundbreaking Quantum Technology® offers a new dimension of accuracy and clarity in oncology imaging. It delivers high image quality, empowering healthcare professionals with the ability to detect, characterize, and monitor tumors with precision.

Whether in high-resolution imaging, high-contrast and low-dose imaging, or spectral imaging, Quantum Technology enables consistent and precise staging and monitoring across the board without any compromises. All relevant CT results can be gained from just a single scan.

Take clinical decision-making to a whole new level by leveraging the visualization of oncologic features such as tumors and tumor feeding vessels.

How to best combine spatial resolution, acquisition speed, and spectral information in one scan? Professor Claudia Lengerke, head of the department of hematology/oncology at University Hospital Tubingen, Germany, and Professor Konstantin Nikolaou, diagnostic and interventional radiology department chair, found the answer with NAEOTOM Alpha.

NAEOTOM Alpha redefines consistency by providing monoenergetic images as the standard image type for every scan. Perform numerical measurements that are independent from the selected scan parameters – and build your clinical decisions on standardized results throughout the patient journey. See for yourself.

Clinical cVRT image of a multi-phasic CME abdomen CT after liver transplantation.
Courtesy of Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands

With Quantum Technology, the dilemma of having to decide before a scan which information is most relevant is a thing of the past. It redefines clinical decision-making by providing all relevant CT results with one single scan – in Quantum HD image quality and without compromising on spectral information or scan speed.

Apply these benefits to detect small liver lesions or pancreatic tumors, take advantage of the potential of virtual-non contrast imaging, evaluate multiple myeloma, or clearly see tumor-feeding vessels.

Clinical image of an abdomen acquired with low dose and contrast media.
Courtesy of Dr. Jones & Partners, SAHMRI, Adelaide, Australia

Quantum Technology is designed to consistently acquire high quality images while optimizing radiation exposure for patients. Compared to conventional CT scanners, the radiation dose can be lowered. This particularly benefits oncology patients who require frequent imaging for treatment monitoring and follow-ups.

The same applies for contrast media usage, where increased contrast-to-noise ratio and inherent low keV imaging capabilities has the potential to enable a reduction of contrast media dose for sensitive patient groups.

Clinical image of a kidney applying inherently available spectral information for the evaluation of challenging lesions.
Courtesy of Charles University Hospital, Pilsen, Czech Republic

Quantum Technology redefines diagnostic consistency by providing monoenergetic images as the standard image type for every scan. Perform numerical measurements independent of scan parameters – and derive clinical decisions from standardized results throughout the patient journey.

Comparability across several acquisitions allows users to confidently determine whether changes between scans are a result of therapy or physiology of the lesion, and not driven by inconsistencies in imaging parameters.

Konstantin Nikolaou, MD, PhD

Discover the full potential of NAEOTOM Alpha photon-counting CT.